These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24969278)

  • 1. Can we change the natural history of Crohn's disease with early immunomodulation?
    Markowitz J
    Dig Dis; 2014; 32(4):345-50. PubMed ID: 24969278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic features of Crohn's disease associated with failure of medical treatment.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Seow CH; Fedorak RN; Dieleman LA; Barkema HW; Ghosh S; Panaccione R;
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):434-42.e1. PubMed ID: 23978351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
    Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
    Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Top-down therapy: is the evidence strong enough?
    Domènech E; Mañosa M; Cabré E
    Dig Dis; 2009; 27(3):306-11. PubMed ID: 19786756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of postoperative recurrence of Crohn's disease.
    van Lent AU; D'Haens GR
    Dig Dis; 2013; 31(2):222-8. PubMed ID: 24030230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Have biologics changed the natural history of Crohn's disease?
    Mandel MD; Miheller P; Müllner K; Golovics PA; Lakatos PL
    Dig Dis; 2014; 32(4):351-9. PubMed ID: 24969279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk/benefit strategies must be employed in the management of pediatric Crohn's disease.
    Hyams JS
    Dig Dis; 2009; 27(3):291-6. PubMed ID: 19786754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical factors predictive of Crohn's disease complications and surgery.
    Cerqueira RM; Lago PM
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):129-34. PubMed ID: 23104203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in Crohn's disease: early and long-term treatment.
    Armuzzi A; De Pascalis B; Fedeli P; De Vincentis F; Gasbarrini A
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S271-9. PubMed ID: 18599000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative recurrence in Crohn's disease].
    Caprilli R; Taddei G; Viscido A
    Chir Ital; 1995; 47(5):25-32. PubMed ID: 9162601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
    Cosnes J; Nion-Larmurier I; Beaugerie L; Afchain P; Tiret E; Gendre JP
    Gut; 2005 Feb; 54(2):237-41. PubMed ID: 15647188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized recording of parameters related to the natural history of inflammatory bowel disease: from Montreal to Paris.
    Hyams JS
    Dig Dis; 2014; 32(4):337-44. PubMed ID: 24969277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation does not alter histology in resected Crohn's disease.
    Frizelle FA; Ing A; Gearry RB; Whitehead M; Faragher IG; Dobbs B
    Tech Coloproctol; 2009 Dec; 13(4):295-300. PubMed ID: 19774438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early versus late surgery for ileo-caecal Crohn's disease.
    Aratari A; Papi C; Leandro G; Viscido A; Capurso L; Caprilli R
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1303-12. PubMed ID: 17848181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of thiopurines on the risk of surgical recurrence in patients with Crohn's disease after first intestinal surgery.
    Papay P; Reinisch W; Ho E; Gratzer C; Lissner D; Herkner H; Riss S; Dejaco C; Miehsler W; Vogelsang H; Novacek G
    Am J Gastroenterol; 2010 May; 105(5):1158-64. PubMed ID: 20010925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive therapy in postoperative Crohn's disease.
    Swoger JM; Regueiro M
    Curr Opin Gastroenterol; 2010 Jul; 26(4):337-43. PubMed ID: 20571386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving management of postoperative Crohn's disease.
    Hashash JG; Regueiro MD
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):637-48. PubMed ID: 23061713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
    Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates.
    Ramadas AV; Gunesh S; Thomas GA; Williams GT; Hawthorne AB
    Gut; 2010 Sep; 59(9):1200-6. PubMed ID: 20650924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.